However_RB ,_, this_DT factor_NN appeared_VBD when_WRB these_DT CML_NN patients_NNS achieved_VBD complete_JJ haematological_JJ remission_NN CHR_NN through_IN alpha-interferon_NN therapy_NN ._.
